GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioCorRx Inc (OTCPK:BICX) » Definitions » Days Sales Outstanding

BioCorRx (BioCorRx) Days Sales Outstanding : 31.22 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is BioCorRx Days Sales Outstanding?

BioCorRx's average Accounts Receivable for the three months ended in Dec. 2023 was $0.01 Mil. BioCorRx's Revenue for the three months ended in Dec. 2023 was $0.02 Mil. Hence, BioCorRx's Days Sales Outstanding for the three months ended in Dec. 2023 was 31.22.

The historical rank and industry rank for BioCorRx's Days Sales Outstanding or its related term are showing as below:

BICX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.97   Med: 17.54   Max: 73.82
Current: 59.88

During the past 13 years, BioCorRx's highest Days Sales Outstanding was 73.82. The lowest was 2.97. And the median was 17.54.

BICX's Days Sales Outstanding is ranked worse than
63.74% of 637 companies
in the Healthcare Providers & Services industry
Industry Median: 46.01 vs BICX: 59.88

BioCorRx's Days Sales Outstanding declined from Dec. 2022 (56.07) to Dec. 2023 (31.22).


BioCorRx Days Sales Outstanding Historical Data

The historical data trend for BioCorRx's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCorRx Days Sales Outstanding Chart

BioCorRx Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.84 2.97 11.41 31.55 73.82

BioCorRx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.07 53.61 57.03 114.06 31.22

Competitive Comparison of BioCorRx's Days Sales Outstanding

For the Medical Care Facilities subindustry, BioCorRx's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioCorRx's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BioCorRx's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BioCorRx's Days Sales Outstanding falls into.



BioCorRx Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BioCorRx's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.035 + 0.001) / 2 ) / 0.089*365
=0.018 / 0.089*365
=73.82

BioCorRx's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.012 + 0.001) / 2 ) / 0.019*365 / 4
=0.0065 / 0.019*365 / 4
=31.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioCorRx  (OTCPK:BICX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


BioCorRx Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BioCorRx's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


BioCorRx (BioCorRx) Business Description

Traded in Other Exchanges
N/A
Address
2390 East Orangewood Avenue, Suite 500, Anaheim, CA, USA, 92806
BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication-assisted treatment program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application.
Executives
Louis C. Lucido director 2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Joseph J Galligan director, 10 percent owner 333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Harsha Murthy director 5209 38TH STREET,NW, WASHINGTON DC 20015
Luisa Ingargiola director 4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
Thomas Patrick Welch officer: Vice President of Operations 10453 SARAH ST., TOLUCA LAKE CA 91602
Kent Emry director, officer: Chief Executive Officer 2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Brady James Granier director 13024 DELANO STREET, VALLEY GLEN CA 91401
Lourdes Felix director, officer: Chief Financial Officer 15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
Jorge Jr Andrade director, officer: Chief Executive Officer PO BOX 5366, SANTA ANA CA 92704
Muller Neil Terrence Mr director, officer: President 13231 SANDHURST PLACE, SANTA ANA CA 92705

BioCorRx (BioCorRx) Headlines

From GuruFocus

BioCorRx Business Update for the First Quarter of 2022

By GuruFocusNews GuruFocusNews 07-06-2022

BioCorRx Provides Business Update for the Third Quarter of 2022

By Value_Insider Value_Insider 11-15-2022

BioCorRx to Present at the LD Micro Invitational XII on June 7th

By GuruFocusNews GuruFocusNews 06-20-2022

BioCorRx to Present at the LD Micro Invitational XII on June 7th

By GuruFocusNews GuruFocusNews 07-10-2022